Browse by category

Semaglutide linked to uncommon blindness condition NAION

Patients prescribed semaglutide (as Ozempic or Wegovy) for diabetes or weight loss had a higher risk of having a potentially blinding eye...

Journal Watch 8/1/2024

10 hours ago

Biomea Fusion announces first data on icovamenib-semaglutide combination study

15 hours ago

MBX Biosciences announces positive phase 1 topline results for MBX 1416 for the treatment of PBH

15 hours ago

Weekly Digest